Enfusion, Inc.

General Information

Our mission is to help solve investment managers’ evolving business and operational challenges through next-generation technology.

Enfusion is a global high-growth software-as-a-service (SaaS) provider focused on transforming the investment management industry. Our cloud-native solution is designed to eliminate technology and information barriers, empowering investment managers to confidently make and execute better informed investment decisions in real time. We simplify investment and operational workflows.

We believe that we are the only solution that allows clients to see and interact with all parts of the investment management lifecycle, ranging from portfolio construction, trading, risk management, accounting and operations to investor reporting seamlessly in real time, in one screen, in one solution. As a result, our solution enables clients to better align teams, optimizing their investment decision-making, operations and technology footprint and lowering operating costs. 

(Note: Enfusion priced its IPO at $17 – the top of its $15-to-$17 range – on 18.75 million shares, the number of shares in the prospectus, to raise $318.75 million.)

Employees: 639
Founded: 1995
Contact Information
Address 125 South Clark Street, Suite 750 Chicago, IL 60603
Phone Number (312) 253-9800
Web Address http://www.enfusion.com/
View Prospectus: Enfusion, Inc.
Financial Information
Market Cap $1808.96mil
Revenues $93.25 mil (last 12 months)
Net Income $1.75 mil (last 12 months)
IPO Profile
Symbol ENFN
Exchange NYSE
Shares (millions): 18.8
Price range $17.00 - $17.00
Est. $ Volume $318.8 mil
Manager / Joint Managers Morgan Stanley/ Goldman Sachs/ BofA Securities/ Credit Suisse
CO-Managers Piper Sandler/ Stifel/ William Blair/ Loop Capital Markets
Expected To Trade: 10/21/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change